• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Celldex Therapeutics Inc

+ Add to Watchlist

CLDX:US

22.7500 USD 0.4000 1.79%

As of 20:10:00 ET on 01/23/2015.

Snapshot for Celldex Therapeutics Inc (CLDX)

Open: 22.4000 Day's Range: 21.8500 - 22.7500 Volume: 1,084,164
Previous Close: 22.3500 52wk Range: 10.7600 - 33.3300 1-Yr Rtn: -16.18%

Stock Chart for CLDX

No chart data available.
  • CLDX:US 22.7500
  • 1D
  • 1M
  • 1Y
22.3500
Interactive CLDX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CLDX

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -1.2300
Est. EPS (USD) (12/2014) -1.3180
Est. PEG Ratio -
Market Cap (M USD) 2,038.15
Shares Outstanding (M) 89.59
30 Day Average Volume 2,163,800
Price/Book (mrq) 8.5146
Price/Sale (ttm) 732.3161
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/03/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CLDX

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for CLDX

Celldex Therapeutics Inc., a biopharmaceutical company, uses applications of immunology to prevent and treat diseases. The Company's products treat autoimmune diseases, cardiovascular diseases, cancer, and inflammation, as well as infectious diseases and organ transplant rejection.

Anthony Salvatore MarucciPresident/CEOThomas DavisExec VP/Chief Medical Officer
Tibor KelerExec VP/Chief Scientific OfficerAvery W Catlin "Chip"Senior VP/CFO/Secretary
More Company Profile & Key Executives for CLDX

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil